NCT04809116View on ClinicalTrials.gov

Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 15, 2022

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions
Insomnia ChronicPosttraumatic Stress Disorder
Interventions
DRUG

Pimavanserin

open-label, fixed-dose pimavanserin 34mg at bedtime for 6 weeks

Trial Locations (1)

77030

Michael E. DeBakey VA Medical Center, Houston

Sponsors
All Listed Sponsors
collaborator

ACADIA Pharmaceuticals Inc.

INDUSTRY

lead

Baylor College of Medicine

OTHER